{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:00:50Z","timestamp":1792555250491,"version":"4.5.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T00:00:00Z","timestamp":1452038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141159","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T18:40:43Z","timestamp":1452105643000},"page":"e0141159","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway"],"prefix":"10.1371","volume":"11","author":[{"given":"Yunyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huakai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,1,6]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/bega.2000.0144","article-title":"Splenomegaly, hypersplenism and coagulation abnormalities in liver disease","volume":"14","author":"PA McCormick","year":"2000","journal-title":"Best Pract Res Cl Ga"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopenia associated with chronic liver disease","volume":"48","author":"N Afdhal","year":"2008","journal-title":"J Hepatol"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/liv.12702","article-title":"Big spleens and hypersplenism: fix it or forget it?","volume":"35","author":"TD Boyer","year":"2015","journal-title":"Liver Int"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1590-8658(02)80246-8","article-title":"Role of spleen enlargement in cirrhosis with portal hypertension","volume":"34","author":"M Bolognesi","year":"2002","journal-title":"Digest Liver Dis"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1113\/expphysiol.2012.064485","article-title":"The spleen is a player in portal hypertension","volume":"97","author":"H Liu","year":"2012","journal-title":"Exp Physiol"},{"issue":"1100","key":"ref6","first-page":"721","article-title":"Experimental congestive splenomegaly: histological observations in the rat","volume":"85","author":"A Manenti","year":"1992","journal-title":"Pathologica"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2010.01.004","article-title":"Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension","volume":"52","author":"M Mejias","year":"2010","journal-title":"J Hepatol"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tcb.2006.02.002","article-title":"Complexity of the TOR signaling network","volume":"16","author":"K Inoki","year":"2006","journal-title":"Trends Cell Biol"},{"issue":"18","key":"ref9","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/sj.onc.1207542","article-title":"Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression","volume":"23","author":"DC Fingar","year":"2004","journal-title":"Oncogene"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2002-01-0109","article-title":"BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1\u03b1, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin","volume":"100","author":"M Mayerhofer","year":"2002","journal-title":"Blood"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"M Guba","year":"2002","journal-title":"Nat Med"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.104.079616","article-title":"Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms","volume":"313","author":"E Biecker","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2006.07.030","article-title":"Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis","volume":"45","author":"M Neef","year":"2006","journal-title":"J Hepatol"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2010.10.044","article-title":"Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis","volume":"55","author":"E Patsenker","year":"2011","journal-title":"J Hepatol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"e83908","DOI":"10.1371\/journal.pone.0083908","article-title":"Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2","volume":"9","author":"W Wang","year":"2014","journal-title":"PloS one"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.21785","article-title":"Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats","volume":"46","author":"M Fernandez","year":"2007","journal-title":"Hepatology"},{"issue":"9615","key":"ref17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"D Schuppan","year":"2008","journal-title":"The Lancet"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"M Mejias","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"ref19","first-page":"697","article-title":"Ki-67 immunoexpression is a robust marker of proliferative cells in the rat","volume":"77","author":"C Gerlach","year":"1997","journal-title":"Lab Invest"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"XM Ma","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"RE Mebius","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"5762","key":"ref22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.1115035","article-title":"Caspases 3 and 7: key mediators of mitochondrial events of apoptosis","volume":"311","author":"SA Lakhani","year":"2006","journal-title":"Science"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease","volume":"50","author":"M Fernandez","year":"2009","journal-title":"J Hepatol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2005.02.022","article-title":"Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats","volume":"43","author":"M Fernandez","year":"2005","journal-title":"J Hepatol"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1134\/S0006297908070031","article-title":"Mechanisms of angiogenesis","volume":"73","author":"AF Karamysheva","year":"2008","journal-title":"Biochemistry (Moscow)"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/gut.7.2.175","article-title":"Injection studies of the splenic vasculature in portal hypertension","volume":"7","author":"F Manenti","year":"1966","journal-title":"Gut"},{"issue":"22","key":"ref27","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.lfs.2007.03.009","article-title":"Splenic hemodynamics and decreased endothelial nitric oxide synthase in the spleen of rats with liver cirrhosis","volume":"80","author":"S Yamaguchi","year":"2007","journal-title":"Life Sci"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/hep.21921","article-title":"Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats","volume":"46","author":"S Tugues","year":"2007","journal-title":"Hepatology"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI12568","article-title":"Transient expression of IL-1\u03b2 induces acute lung injury and chronic repair leading to pulmonary fibrosis","volume":"107","author":"M Kolb","year":"2001","journal-title":"J Clin Invest"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-\u03baB: a key role in inflammatory diseases","volume":"107","author":"PP Tak","year":"2001","journal-title":"J Clin Invest"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"SL Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1053\/jhep.2002.0350964","article-title":"Inflammation in response to hepatocellular apoptosis","volume":"35","author":"H Jaeschke","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"ref33","first-page":"G119","article-title":"Mitochondrial biogenesis fails in secondary biliary cirrhosis in rats leading to mitochondrial DNA depletion and deletions","volume":"301","author":"A Arduini","year":"2011","journal-title":"Am J Physiol-Gastr L"},{"issue":"9930","key":"ref34","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"EA Tsochatzis","year":"2014","journal-title":"The Lancet"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1074\/jbc.271.2.736","article-title":"Interleukin 6 induces the expression of vascular endothelial growth factor","volume":"271","author":"T Cohen","year":"1996","journal-title":"J Biol Chem"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1096\/fasebj.11.6.9194526","article-title":"The codependence of angiogenesis and chronic inflammation","volume":"11","author":"JR Jackson","year":"1997","journal-title":"FASEB J"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2006.12.008","article-title":"Targeting mammalian target of rapamycin (mTOR) for health and diseases","volume":"12","author":"CK Tsang","year":"2007","journal-title":"Drug Discov Today"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1872-034X.2008.00369.x","article-title":"Rapamycin prevents mesenteric neo-angiogenesis and reduces splanchnic blood flow in portal hypertensive mice","volume":"38","author":"AM Geerts","year":"2008","journal-title":"Hepatol Res"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.transproceed.2014.03.011","article-title":"Effect of Rapamycin on Spleen Size in Longstanding Renal Transplant Recipients","volume":"46","author":"NC Ara\u00fajo","year":"2014","journal-title":"Transpl P"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T07:04:24Z","timestamp":1567494264000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141159"}},"subtitle":[],"editor":[{"given":"Gianfranco","family":"Alpini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141159","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,6]]}}}